Frédéric Collet

Frédéric Collet is an expert in health strategy and the President of Bionnassay Consult, specializing in the pharmaceutical industry and healthcare political landscapes. They served as General Director at Novartis Oncology from 2015 to 2022 and held leadership positions at several prominent companies, including Sandoz and CIBA Vision. Currently, Frédéric is an Administrator at Institut Imagine, President of the Filière Intelligence Artificielle & Cancers, and a Senior Advisor at Eurazeo, among other roles. They hold a Master's degree in Economic Science from Paris-Pantheon-Assas University and has completed executive programs at Harvard Business School and Harvard T.H. Chan School of Public Health.